| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15:06 | Adial Pharmaceuticals applies for FDA priority voucher program | ||
| 15:06 | Thermo Fisher to sell microbiology unit to Astorg for $1.08 billion | ||
| 15:06 | Akari Therapeutics secures Australian patent for ADC payload | ||
| 15:06 | Aspire Biopharma authorizes $5 million stock buyback program | ||
| 15:06 | Evercore ISI raises AZZ stock price target to $152 on galvanizing demand | ||
| 15:06 | Tigress Financial initiates Oklo stock coverage with buy rating | ||
| 15:06 | Freedom Broker initiates Quaker Houghton stock with buy rating | ||
| 14:42 | ACM Research expects Q1 revenue of $225M to $230M | ||
| 14:42 | Tenaya to present TN-401 gene therapy trial data at ASGCT | ||
| 14:42 | Big Digital Energy signs colocation deal with management affiliate | ||
| 14:42 | LiveRamp adds NVIDIA GPU support to clean room platform | ||
| 14:42 | Solana Company raises $8M through stock offering | ||
| 14:42 | La Rosa restates 2024 revenue down $10.8M on accounting change | ||
| 14:42 | Critical Metals proposes $835M acquisition of European Lithium | ||
| 14:42 | Roadzen's VehicleCare wins major contract with Indian insurer | ||
| 14:42 | Citizens Community Bancorp reports Q1 earnings of $3.8 million | ||
| 14:42 | Stephens raises First American Financial stock price target on commercial strength | ||
| 14:30 | Amedeo Air Four Plus shareholders approve Lesha Bank acquisition | ||
| 14:30 | AbbVie seeks FDA approval for Skyrizi subcutaneous induction | ||
| 14:30 | Oncolytics aligns with FDA on pivotal trial design for anal cancer | ||
| 14:30 | iRhythm study shows 14-day monitoring detects more arrhythmias | ||
| 14:30 | TERN-701 receives FDA breakthrough therapy designation for CML | ||
| 14:30 | GameSquare Experiences reports $10M in Q1 2026 bookings | ||
| 14:30 | Burcon closes $6.9 million convertible debenture financing | ||
| 14:30 | Woodward declares $0.32 quarterly dividend |